Milestone Scientific (Milestone Scientific) EBIT : $-7.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Milestone Scientific EBIT?

Milestone Scientific's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-1.98 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.11 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Milestone Scientific's annualized ROC % for the quarter that ended in Dec. 2023 was -301.71%. Milestone Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -327.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Milestone Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -16.95%.

Milestone Scientific EBIT Historical Data

The historical data trend for Milestone Scientific's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific EBIT Chart

Milestone Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-4.00

-7.45

-7.38

-8.83

-7.11

Milestone Scientific Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															-2.02	-1.34	-2.28	-1.51	-1.98

Competitive Comparison of Milestone Scientific's EBIT

For the Medical Instruments & Supplies subindustry, Milestone Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Scientific's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's EV-to-EBIT falls into.

Milestone Scientific EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.11 Mil.

Milestone Scientific (AMEX:MLSS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Milestone Scientific's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-7.92 * ( 1 - 0% )	/	( (2.795	+	2.455)	/ 2 )
=	-7.92	/	2.625
=	-301.71 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.584	-	3.168	-	( 4.621	-	max(0, 3.279	-	9.973	+	4.621	))
=	2.795

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11.372	-	2.963	-	( 5.954	-	max(0, 3.077	-	10.794	+	5.954	))
=	2.455

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Milestone Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-7.92	/	( ( (0.398 + max(2.183, 0))	+	(0.374 + max(1.877, 0)) )	/	2 )
=	-7.92	/	( ( 2.581	+	2.251 )	/	2 )
=	-7.92	/	2.416
=	-327.81 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.591	+	2.483	+	2.278)	-	(3.168	+	0	+	0.00099999999999989)
=	2.183

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.313	+	2.638	+	1.889)	-	(2.963	+	0	+	0)
=	1.877

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Milestone Scientific's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-7.108	/	41.935
	=	-16.95 %

Milestone Scientific EBIT Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Milestone Scientific (Milestone Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

425 Eagle Rock Avenue, Roseland, NJ, USA, 07068

Website

https://www.milestonescientific.com

Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.

Executives

Peter J Milligan	officer: President	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman	director	170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard	director	C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento	director	200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser	director, 10 percent owner, officer: CEO
Leonard M Schiller	director
Scott L. Kahn	officer: Chief Financial Officer	425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta	director, 10 percent owner	CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino	officer: CFO & COO	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals	officer: President	110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston	officer: President	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan	director	C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick	director	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger	officer: President and CEO	24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l.	director, 10 percent owner, officer: See Remarks	CORSO VENEZIA 44, MILAN L6 20121